Pacira BioSciences, Inc. (NASDAQ:PCRX) has risen 24.65% since May 5, 2018 and is uptrending. It has outperformed by 20.28% the S&P500.
News
- Partner Investment Management LP Position in Pacira Pharmaceuticals (PCRX) Has Trimmed by ...
- Study asks patients' input to improve the hospital experience
SAN ANTONIO - American hospitals engage in continuous quality and ... nursing, dentistry, health professions and graduate biomedical sciences ...
- Mayoral Elections Saturday in 3 of Largest Cities in Texas
Eric Johnson, philanthropist and former biotech executive Lynn McBee and ... There are also nine candidates in San Antonio, where Mayor Ron ...
- NASA Twins Study reveals health effects of space flight
While further study is needed, the NIH-funded team led by Kumar Sharma, University of Texas Health Science Center, San Antonio, suggests ... I look forward to future space missions and their contributions to biomedical research.
- Initial public offerings scheduled to debut next week
Business: Phase 2 biotech developing therapies for diabetic ... Business: Clinical-stage biotech developing next-gen cancer immunotherapies.